IKOMED Technologies Inc.: federal grants and contributions: 17 agreements; $2.2M value; 2 departments; 5 programs.
Assay record ASY-CA-07RBDPS132 · Cite as: Assay Systems, “IKOMED Technologies Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/ikomed-technologies-inc/
Scaling up and validation of a medical device for non-invasive treatment of emphysema using RF radiation.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
The project will focus on the development of hardware and software components of emphysema treatment solution towards clinical use in first-in-human trials.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
This International Co-Innovation Action Program (ICAP) project will prepare the firm to enter into future international co-innovation work.
Development of non-invasive thermometry for prototyping and experimental investigation and development of tools to simulate interaction of Radio Frequency with biological tissue layers in the human torso.
To provide employment to a recent Engineering grad in a role of Design Engineer.
To provide employment for a recent grad in Biomedical Engineering.
The Project will support development of intellectual property capacity within the Firm.
Participation in the Canadian Life Sciences co-innovation mission to Japan – October 6 to 10, 2025. Delegation led by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to explore the Japanese market and to develop international partnerships and potential project ideas under the Japan Program. In Partnership with the Trade Commissioner Service Canadian Technology Accelerator (TCS CTA), and Deep Tech Canada, the Canadian delegation will also receive support for their international business and market-entry strategies, as well as get introductions to other
The purpose of the Canadian International Innovation Program (CIIP) contribution agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
Ikomed is commercializing its proprietary technology to reduce radiation in fluoroscopy while maintaining image quality. The firm wishes to hire a junior mechanical engineer to augment its development team.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.